BioCryst Pharmaceuticals Inc (BCRX)
New Form 8-K - BIOCRYST PHARMACEUTICALS INC Filed: 2025-06-30 AccNo: 0001140361-25-024089 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
New Form 8-K - BIOCRYST PHARMACEUTICALS INC Filed: 2025-06-30 AccNo: 0001140361-25-024089 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
There are no comments here yet...